Curanex Pharmaceuticals Inc Debt Instrument, Interest Rate, Effective Percentage
Curanex Pharmaceuticals Inc (CURX) had Debt Instrument, Interest Rate, Effective Percentage of 4.34% as of 2025-05-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Debt Instruments
us-gaap:DebtInstrumentInterestRateEffectivePercentage · last filed 2026-03-30
- 2025-05-31: Debt Instrument, Interest Rate, Effective Percentage 4.34%.
- 2025-02-28: Debt Instrument, Interest Rate, Effective Percentage 4.34%.
| Period end | Debt Instrument, Interest Rate, Effective Percentage |
|---|---|
| 2025-05-31 | 4.34% 10-K · filed 2026-03-30 |
| 2025-02-28 | 4.34% 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |